c-Cbl-mediated degradation of TRAIL receptors is responsible for the development of the early phase of TRAIL resistance

Cellular Signalling

Volumn 22, Issue 3, 2010, Pages 553-563

  Song, Jae J ^a,b   Szczepanski, Miroslaw Jerzy ^d   Kim, So Young ^a,e   Kim, Joo Hang ^a,e   An, Jee Young ^c   Kwon, Yong Tae ^c   Alcala Jr , Marco A ^b   Bartlett, David L ^b   Lee, Yong J ^b  

^a Yonsei University College of Medicine   (South Korea)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c Universigy of Pittsburgh   (United States)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^e Yonsei University College of Medicine   (South Korea)

Author keywords

c Cbl; TRAIL; TRAIL receptors; TRAIL resistance

Indexed keywords

ADAPTOR PROTEIN; CBL PROTEIN; DEATH RECEPTOR 4; DEATH RECEPTOR 5; PROTEIN BCL XL; PROTEIN KINASE B; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ARTICLE; CONTROLLED STUDY; CYTOPLASM; DRUG RESISTANCE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INTERNALIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; UBIQUITINATION;

AMINO ACID SUBSTITUTION; CELL LINE, TUMOR; HUMANS; MUTAGENESIS, SITE-DIRECTED; PROTO-ONCOGENE PROTEINS C-CBL; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RNA, SMALL INTERFERING; TNF-RELATED APOPTOSIS-INDUCING LIGAND; UBIQUITINATION;

EID: 71549148033     PISSN: 08986568     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellsig.2009.11.012     Document Type: Article

References (43)

1. Song J.J., An J.Y., Kwon Y.T., and Lee Y.J. J. Biol. Chem. 282 (2007) 319
2. Zhu H., Zhang L., Huang X., Davis J.J., Jacob D.A., Teraishi F., and Chiao P. B. Fang. Mol. Ther. 9 (2004) 666
3. LeBlanc H.N., and Ashkenazi A. Cell Death Differ. 10 (2003) 66
4. Ashkenazi A. Nat. Rev. Cancer 2 (2002) 420
5. Degli-Esposti M.A., Dougall W.C., Smolak P.J., Waugh J.Y., Smith C.A., and Goodwin R.G. Immunity 7 (1997) 813
6. Jin Z., Dicker D.T., and El-Deiry W.S. Cell Cycle 1 (2002) 82
7. Zhang X.D., Franco A.V., Nguyen T., Gray C.P., and Hersey P. J. Immunol. 164 (2000) 3961
8. Almasan A., and Ashkenazi A. Cytokine Growth Factor Rev. 14 (2003) 337
9. Emery J.G., McDonnell P., Burke M.B., Deen K.C., Lyn S., Silverman C., Dul E., Appelbaum E.R., Eichman C., DiPrinzio R., Dodds R.A., James I.E., Rosenberg M., Lee J.C., and Young P.R. J. Biol. Chem. 273 (1998) 14363
10. Kohlhaas S.L., Craxton A., Sun X.M., Pinkoski M.J., and Cohen G.M. J. Biol. Chem. 282 (2007) 12831
11. Ravid T., Heidinger J.M., Gee P., Khan E.M., and Goldkorn T. J. Biol. Chem. 279 (2004) 37153
12. Waterman H., and Yarden Y. FEBS Lett. 490 (2001) 142
13. Schmidt M.H., Furnari F.B., Cavenee W.K., and Bögler P. Proc. Natl. Acad. USA 100 (2003) 6505
14. Höller D., and Dikic I. Biochem. Pharmacol. 67 (2004) 1013
15. Hicke L., and Dunn R. Annu. Rev. Cell Dev. Biol. 19 (2003) 141
16. Haglund K., Di Fiore P.P., and Dikic I. Trends Biochem. Sci. 28 (2003) 598
17. Haglund K., Sigismund S., Polo S., Szymkiewicz I., Di Fiore P.P., and Dikic I. Nat. Cell Biol. 5 (2003) 461
18. Wernick N.L., Haucke V., and Simister N.E. J. Biol. Chem. 280 (2005) 7309
19. Bonifacino J.S., and Traub L.M. Annu. Rev. Biochem. 72 (2003) 395
20. Belouzard S., Belouzard S., and Rouillé Y. EMBO J. 25 (2006) 932
21. Soubeyran P., Kowanetz K., Szymkiewicz I., Langdon W.Y., and Dikic I. Nature 416 (2002) 183
22. Sanjay A., Horne W.C., and Baron R. Sci STKE 110 (2001) PE40
23. Thien C.B., and Langdon W.Y. Nat. Rev. Mol. Cell Biol. 2 (2001) 294
24. Liu J., Kimura A., Baumann C.A., and Saltiel A.R. Mol. Cell Biol. 22 (2002) 3599
25. Hu J., and Hubbard S.R. J. Biol. Chem. 280 (2005) 18943
26. Pan G., O′Rourke K., Chinnaiyan A.M., Gentz R., Ebner R., Ni J., and Dixit V.M. Science 276 (1997) 111
27. Walczak H., Degil-Esposti M.A., Johnson R.S., Smolak P.J., Waugh J.Y., Boiani N., Timour M.S., Gerhart M.J., Schooley K.A., Smith C.A., Goodwin R.G., and Rauch C.T. EMBO J. 16 (1997) 5386
28. Tsygankov A.Y., Teckchandani A.M., Feshchenko E.A., and Swaminathan G. Oncogene 20 (2001) 6382
29. Andoniou C.E., Thien C.B., and Langdon W.Y. Oncogene 12 (1996) 1981
30. Feshchenko E.A., Langdon W.Y., and Tsygankov A.Y. J. Biol. Chem. 273 (1998) 8323
31. Ota Y., Beitz L.O., Scharenberg A.M., Donovan J.A., Kinet J.P., and Samelson L.E. J. Exp. Med. 184 (1996) 1713
32. Take H., Watanabe S., Takeda K., Yu Z.X., Iwata N., and Kajigaya S. Biophys. Res. Commun. 268 (2000) 321
33. Hunter S., Burton E.A., Wu S.C., and Anderson S.M. J. Biol. Chem. 274 (1999) 2097
34. Hunter S., Koch B.L., and Anderson S.M. Mol. Endocrinol. 11 (1997) 1213
35. Kassenbrock C.K., and Anderson S.M. J. Biol. Chem. 279 (2004) 28017
36. Levkowitz Z., Waterman H., Ettenberg S.A., Katz M., Tsyqankov A.Y., Alroy I., Lavi S., Iwai K., Reiss Y., Ciechanover A., Lipkowitz S., and Yarden Y. Y. Mol. Cell 4 (1999) 1029
37. Lee K.H., Feig C., Tchikov V., Schickel R., Hallas C., Schütze S., Peter M.E., and Chan A.C. EMBO J. 25 (2006) 1009
38. Schneider-Brachert W., Tchikov V., Merkel O., Jacob M., Hallas C., Kruse M.L., Groitl P., Lehn A., Hildt E., Held-Feindt J., Dobner T., Kabelitz D., Krönke M., and Schütze S. J. Clin. Invest. 116 (2006) 2901
39. Kelley S.K., and Ashkenazi A. Cur. Opin. Pharmacol. 4 (2004) 333
40. Mosesson Y., Shtiegman K., Katz M., Zwang Y., Vereb G., Szollosi J., and Yarden Y. J. Biol. Chem. 278 (2003) 21323
41. Duan L., Miura Y., Dimri M., Majumder B., Dodge I.L., Reddi A.L., Ghosh A., Fernandes N., Zhou P., Mullane-Robinson K., Rao N., Donoghue S., Rogers R.A., Bowtell D., Naramura M., Gu H., Band V., and Band H. J. Biol. Chem. 278 (2003) 28950
42. Lee P.S., Wang Y., Dominguez M.G., Yeung Y.G., Murphy M.A., Bowtell D.D., and Stanley E.R. EMBO J. 18 (1999) 3616
43. Levkowitz G., Waterman H., Zamir E., Kam Z., Oved S., Langdon W.Y., Beguinot L., Geiger B., and Yarden Y. Genes Dev. 12 (1998) 3663